When the love is lost: Adalimumab for patients with an attenuated response to infliximab

Inflammatory Bowel Diseases

Volumn 11, Issue 10, 2005, Pages 948-949

  Dassopoulos, Themistocles ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; ADALIMUMAB; IMMUNOMODULATING AGENT; INFLIXIMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; THALIDOMIDE;

ADULT; CLINICAL ARTICLE; CROHN DISEASE; DRUG EFFICACY; DRUG TOLERANCE; ERYTHEMA; FEMALE; HUMAN; INJECTION SITE REACTION; MALE; NOTE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 26444461520     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/01.MIB.0000183426.41587.db     Document Type: Note

References (7)

1. Gastroenterology. 2004;126:402-413.
2. Gastroenterology. 2004;126(Suppl 2):A631.
3. Clin Gastroenterol Hepatol. 2004;2:542-553.
4. N Engl J Med. 2003;348:601-608.
5. Inflamm Bowel Dis. 2004;10:333-338.
6. Am J Gastroenterol. 2004;99:1984-1989.
7. Gastroenterology. 2004;127:332.